Adjuvant Chemotherapy for Stage II Colon Cancer: The Role of Molecular Markers in Choosing Therapy

by Chun, Patrick, Wainberg, Zev A.
Published 2009

Targeted Therapies for Metastatic Esophagogastric Cancer

by Reddy, Deepa, Wainberg, Zev A.
Published 2011

Safety Considerations of Cancer Nanomedicine – A key step towards translation

by Liu, Xiangsheng, Tang, Ivanna, Wainberg, Zev A., Meng, Huan
Published in Small (2020)

Initial Report of Second‐Line FOLFIRI in Combination with Ramucirumab in Advanced Gastroesophageal Adenocarcinomas: A Multi‐Institutional Retrospective Analysis

by Klempner, Samuel J., Maron, Steven B., Chase, Leah, Lomnicki, Samantha, Wainberg, Zev A., Catenacci, Daniel V.T.
Published in Oncologist (2018)

A Phase II Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First‐Line Treatment of Pancreatic Adenocarcinoma...

by Benson, Al B., Wainberg, Zev A., Hecht, J. Randolph, Vyushkov, Dmitry, Dong, Hua, Bendell, Johanna, Kudrik, Fred
Published in Oncologist (2017)

Optimising the use of cetuximab in the continuum of care for patients with metastatic colorectal cancer

by Goldberg, Richard M, Montagut, Clara, Wainberg, Zev A, Ronga, Philippe, Audhuy, François, Taieb, Julien, Stintzing, Sebastian, Siena, Salvatore, Santini, Daniele
Published in ESMO Open (2018)

Talazoparib has no clinically relevant effect on QTc interval in patients with advanced solid tumors

by Hoffman, Justin, Chakrabarti, Jayeta, Plotka, Anna, Milillo Naraine, Adriana, Kanamori, David, Moroose, Rebecca, Nguyen, Linh, Wang, Diane, Wainberg, Zev A.
Published in Anticancer Drugs (2019)

Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: A pilot study

by Britten, Carolyn D, Gomes, Antoinette S, Wainberg, Zev A, Elashoff, David, Amado, Rafael, Xin, Yan, Busuttil, Ronald W, Slamon, Dennis J, Finn, Richard S
Published 2012

CA19-9 Normalization During Pre-Operative Treatment Predicts Longer Survival for Patients with Locally Progressed Pancreatic Cancer

by Williams, Jennifer L., Kadera, Brian E., Nguyen, Andrew H., Muthusamy, V. Raman, Wainberg, Zev A., Hines, O. Joe, Reber, Howard A., Donahue, Timothy R.
Published in J Gastrointest Surg (2016)

Phase III Study to Evaluate Efficacy and Safety of Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1)

by Shah, Manish A., Bodoky, Gyorgy, Starodub, Alexander, Cunningham, David, Yip, Desmond, Wainberg, Zev A., Bendell, Johanna, Thai, Dung, He, Joyce, Bhargava, Pankaj, Ajani, Jaffer A.
Published in J Clin Oncol (2021)

A phase 1, open-label, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in subjects with relapsed or refractory solid tumors

by von Mehren, Margaret, Britten, Carolyn D., Pieslor, Peter, Saville, Wayne, Vassos, Artemios, Harris, Sarah, Galluppi, Gerald R., Darif, Mohamed, Wainberg, Zev A., Cohen, Roger B., Leong, Stephen
Published 2014

Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabi...

by Wainberg, Zev A., Feeney, Kynan, Lee, Myung Ah, Muñoz, Andrés, Gracián, Antonio Cubillo, Lonardi, Sara, Ryoo, Baek-Yeol, Hung, Annie, Lin, Yong, Bendell, Johanna, Hecht, J. Randolph
Published in BMC Cancer (2020)

Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer

by Court, Colin M., Ankeny, Jacob S., Sho, Shonan, Winograd, Paul, Hou, Shuang, Song, Min, Wainberg, Zev A., Girgis, Mark D., Graeber, Thomas G., Agopian, Vatche G., Tseng, Hsian-Rong, Tomlinson, James S.
Published in Ann Surg Oncol (2018)

Reality of Single Circulating Tumor Cell Sequencing for Molecular Diagnostics in Pancreatic Cancer

by Court, Colin M., Ankeny, Jacob S., Sho, Shonan, Hou, Shuang, Li, Qingyu, Hsieh, Carolyn, Song, Min, Liao, Xinfang, Rochefort, Matthew M., Wainberg, Zev A., Graeber, Thomas G., Tseng, Hsian-Rong, Tomlinson, James S.
Published in J Mol Diagn (2016)

Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma

by Catenacci, Daniel V.T., Rasco, Drew, Lee, Jeeyun, Rha, Sun Young, Lee, Keun-Wook, Bang, Yung Jue, Bendell, Johanna, Enzinger, Peter, Marina, Neyssa, Xiang, Hong, Deng, Wei, Powers, Janine, Wainberg, Zev A.
Published in J Clin Oncol (2020)

Combination Chemo‐Immunotherapy for Pancreatic Cancer Using the Immunogenic Effects of an Irinotecan Silicasome Nanocarrier Plus Anti‐PD‐1

by Liu, Xiangsheng, Jiang, Jinhong, Liao, Yu‐Pei, Tang, Ivanna, Zheng, Emily, Qiu, Waveley, Lin, Matthew, Wang, Xiang, Ji, Ying, Mei, Kuo‐Ching, Liu, Qi, Chang, Chong Hyun, Wainberg, Zev A., Nel, Andre E., Meng, Huan
Published in Adv Sci (Weinh) (2021)

Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance

by Tanaka, Hiroshi, Kono, Evelyn, Tran, Chau P, Miyazaki, Hideyo, Yamashiro, Joyce, Shimomura, Tatsuya, Fazli, Ladan, Wada, Robert, Huang, Jiaoti, Vessella, Robert L, An, Jaibin, Horvath, Steven, Gleave, Martin, Rettig, Matthew B, Wainberg, Zev A, Reiter, Robert E
Published 2010

Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600–Mutant Anaplastic Thyroid Cancer

by Subbiah, Vivek, Kreitman, Robert J., Wainberg, Zev A., Cho, Jae Yong, Schellens, Jan H.M., Soria, Jean Charles, Wen, Patrick Y., Zielinski, Christoph, Cabanillas, Maria E., Urbanowitz, Gladys, Mookerjee, Bijoyesh, Wang, Dazhe, Rangwala, Fatima, Keam, Bhumsuk
Published in J Clin Oncol (2018)

A Multi-Arm Phase I Study of the PI3K/mTOR Inhibitors PF-04691502 and Gedatolisib (PF-05212384) plus Irinotecan or the MEK Inhibitor PD-0325901 in Advanced Cancer

by Wainberg, Zev A., Alsina, Maria, Soares, Heloisa P., Braña, Irene, Britten, Carolyn D., Del Conte, Gianluca, Ezeh, Patrick, Houk, Brett, Kern, Kenneth A., Leong, Stephen, Pathan, Nuzhat, Pierce, Kristen J., Siu, Lillian L., Vermette, Jennifer, Tabernero, Josep
Published in Target Oncol (2017)

Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon Cancer

by Liu, Xiangsheng, Jiang, Jinhong, Chan, Ryan, Ji, Ying, Lu, Jianqin, Liao, Yu-Pei, Okene, Michael, Lin, Joshua, Lin, Paulina, Chang, Chong Hyun, Wang, Xiang, Tang, Ivanna, Zheng, Emily, Qiu, Waveley, Wainberg, Zev A., Nel, Andre E., Meng, Huan
Published in ACS Nano (2018)